Maxim Group Maintains Rani Therapeutics(RANI.US) With Buy Rating, Maintains Target Price $15
Watching Rani Therapeutics; Zacks Small-Cap Research Gives Stock $12 Price Valuation
Oppenheimer Maintains Rani Therapeutics(RANI.US) With Buy Rating, Maintains Target Price $17
Analysts Are Bullish on These Healthcare Stocks: Avadel Pharmaceuticals (AVDL), Rani Therapeutics Holdings (RANI)
Rani Therapeutics Hldgs Analyst Ratings
H.C. Wainwright Maintains Rani Therapeutics(RANI.US) With Buy Rating, Maintains Target Price $9
Buy Rating Affirmed for Rani Therapeutics: Promising Developments in Oral Obesity Treatment With RaniPill
Rani Therapeutics(RANI.US) 10% Shareholder Sells US$10.14 Million in Common Stock
$Rani Therapeutics(RANI.US)$ 10% Shareholder South Cone Investments Limited Partnership sold 3.83 million shares of common stock on Oct 15, 2024 at an average price of $2.6484 for a total value of $10
Express News | Rani Therapeutics Holdings Inc - Phase 1 Study for Rt-114 Expected to Initiate in 2025
Express News | Rani Therapeutics Holdings Inc - New Data Supports Ranipill Platform for Oral Obesity Treatments
Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist
Why Rani Therapeutics Shares Are Down 23% Today
Express News | Rani Therapeutics Holdings Inc - Combined Purchase Price of $3.00 per Share
Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering and Cancellation of Certain Existing Warrants
Daily options tracking | Nvidia refreshes historical highest closing price, multiple Friday expiration call options doubled; U.S. version of Huabei SOFI surged 11%, one call option made a whopping 13 times profit.
Cryptos surged, with a significant increase in options volume for related concept stocks. Among them, Coinbase rose by 11.32%, with an options volume of 0.5797 million contracts, and a call ratio of 84.4%.
12 Health Care Stocks Moving In Monday's Pre-Market Session
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 47%; Here Are 20 Stocks Moving Premarket
Pleasing Signs As A Number Of Insiders Buy Rani Therapeutics Holdings Stock
Rani Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit
Rani Therapeutics to Participate in September Investor Conferences
No Data
No Data